Written by Antonia di Lorenzo || 23rd June 2022 || News analysis || FDA | Regulation and Legislation | North America United States
Juul Labs says it will contest a marketing denial order (MDO) issued by the US Food and Drug Administration (FDA), effectively ordering all its products off the US market.
Under the order the company must stop selling and distributing all of its products currently on sale in the US. In addition, those already in the market must be removed, or risk enforcement action. ...
Are you already a subscriber? login here
Enjoy free subscription access
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Benefits of subscription plans:
- Stay informed of any legal and market change in the sector that impacts your organization
- Maximise resources by getting market and legal data analysis daily in one place
- Make smart decisions by understanding how the regulatory and market landscape evolves
- Anticipate risks in your decisions by monitoring regulatory changes that impact your organization